| Publicly Available Documents | Size (kB) |
| Only Available after Expression of Interest |
| 01 - ITT_Antibodies & Sera FINAL.doc |
| 01 - ITT_Antibodies & Sera FINAL.docx |
| Appendix A - Selection Questionnaire.xlsx |
| Appendix B1 - Antibodies Award Questionnaire_FINAL.xlsx |
| Appendix B2 - Sera Award Questionnaire_FINAL.xlsx |
| Appendix C - Form of Offer.doc |
| Appendix C - Form of Offer.docx |
| Appendix D - Service Level Agreement (SLA) Target for 2021-22.doc |
| Appendix D - Service Level Agreement (SLA) Target for 2021-22.docx |
| Appendix E - Parent Company Declaration Template_Antibodies.doc |
| Appendix E - Parent Company Declaration Template_Antibodies.docx |
| Appendix G - NDA_Antibodies & Sera.doc |
| Appendix G - NDA_Antibodies & Sera.docx |
| Appendix I - Commitment to Ethical Supply Chain_Antibodies & Sera_2021.doc |
| Appendix I - Commitment to Ethical Supply Chain_Antibodies & Sera_2021.docx |
| Appendix J - Desk Top Calculator Antibodies & Sera 2021.xlsx |
| Appendix K – Scoring Guidance.doc |
| Appendix K – Scoring Guidance.docx |
| Schedule 1 – Framework Agreement – Antibodies & Sera.doc |
| Schedule 2 - Specification of Requirements FINAL.doc |
| Schedule 2 - Specification of Requirements FINAL.docx |
| Schedule 3 - Call Off Agreement - Antibodies & Sera.doc |